Clinical Approach to Seizures
Pediatric Neurology Framework1. Symptom Overview
Understanding the clinical significance and classification of seizures in children
Seizures are one of the most common neurological emergencies in pediatrics, affecting approximately 4-10% of children during the first 16 years of life. Approximately 150,000 children in the United States experience a first unprovoked seizure annually. Febrile seizures alone occur in 2-5% of children between 6 months and 5 years of age. Epilepsy, defined as recurrent unprovoked seizures, affects approximately 0.5-1% of children, making it one of the most common chronic neurological conditions in childhood. Seizures account for approximately 1-2% of all pediatric emergency department visits and represent a significant source of anxiety for families and healthcare providers alike.
Definition
A seizure is a transient occurrence of signs and/or symptoms due to abnormal excessive or synchronous neuronal activity in the brain. This results from an imbalance between excitatory and inhibitory neurotransmission, leading to hypersynchronous electrical discharges that manifest as alterations in motor function, sensation, behavior, or consciousness. Seizures may be provoked (acute symptomatic) or unprovoked, and understanding this distinction is fundamental to management and prognosis.
Key Epidemiology in Children
- Incidence: 25-70 per 100,000 children per year for unprovoked seizures
- Febrile seizures: Most common seizure type in children; peak incidence at 18 months
- Neonatal seizures: Occur in 1-3.5 per 1,000 live births; higher in preterm infants
- Status epilepticus: 18-23 per 100,000 children per year; higher mortality in younger children
- Recurrence risk: 30-50% after first unprovoked seizure; higher with abnormal electroencephalogram or neuroimaging
Classification by Duration and Context
| Category | Definition | Common Causes | Clinical Significance |
|---|---|---|---|
| Brief Seizure | Less than 5 minutes | Febrile seizures, idiopathic epilepsy, benign epilepsy syndromes | Most seizures self-terminate; observe and assess for underlying cause |
| Prolonged Seizure | 5-30 minutes | Febrile status, symptomatic epilepsy, acute brain injury | Requires active intervention; risk of neuronal injury increases with duration |
| Status Epilepticus | Greater than 5 minutes of continuous seizure activity OR two or more seizures without return to baseline | Acute symptomatic causes, medication non-compliance, febrile status, CNS infection | Medical emergency; immediate treatment required; associated with significant morbidity and mortality |
| Refractory Status Epilepticus | Seizure continuing despite two appropriate antiseizure medications | Severe acute brain injury, autoimmune encephalitis, genetic epilepsy syndromes | Requires intensive care; consider anesthetic agents; high mortality risk |
Classification by Etiology
| Category | Definition | Examples in Children | Prognosis |
|---|---|---|---|
| Acute Symptomatic (Provoked) | Seizure occurring in close temporal relationship with an acute central nervous system insult | Febrile seizures, meningitis, encephalitis, head trauma, hypoglycemia, electrolyte disturbances, toxic ingestion | Generally good if underlying cause is treated; lower recurrence risk than unprovoked seizures |
| Unprovoked | Seizure occurring without an identified acute precipitant | Idiopathic epilepsy, remote symptomatic (prior brain injury), genetic epilepsy syndromes | 30-50% recurrence risk after first seizure; diagnosis of epilepsy after two unprovoked seizures |
| Remote Symptomatic | Unprovoked seizure in a child with prior central nervous system injury | Prior hypoxic-ischemic encephalopathy, prior meningitis, cortical malformation, perinatal stroke | Higher recurrence risk; often requires long-term antiseizure medication |
Classification by Seizure Type (ILAE 2017)
Focal Onset Seizures
Originate within networks limited to one hemisphere. May be discretely localized or more widely distributed.
- Focal Aware: Consciousness preserved; previously called simple partial
- Focal Impaired Awareness: Consciousness impaired; previously called complex partial
- Focal to Bilateral Tonic-Clonic: Begins focal, then spreads to involve both hemispheres
Motor features: Automatisms, atonic, clonic, epileptic spasms, hyperkinetic, myoclonic, tonic
Non-motor features: Autonomic, behavior arrest, cognitive, emotional, sensory
Generalized Onset Seizures
Originating at some point within, and rapidly engaging, bilaterally distributed networks.
- Generalized Tonic-Clonic: Stiffening followed by rhythmic jerking; loss of consciousness
- Absence: Brief staring spells with arrest of activity; 3 Hz spike-wave on EEG
- Myoclonic: Brief, shock-like jerks of a muscle or group of muscles
- Atonic: Sudden loss of muscle tone; “drop attacks”
- Tonic: Sustained increase in muscle contraction
- Clonic: Rhythmic jerking movements
Age-Specific Seizure Presentations
| Age Group | Common Seizure Types | Common Epilepsy Syndromes | Special Considerations |
|---|---|---|---|
| Neonates (0-28 days) | Subtle (ocular, oral, cycling movements), clonic, tonic, myoclonic | Benign familial neonatal epilepsy, early myoclonic encephalopathy, Ohtahara syndrome | Seizures often subtle and easily missed; high risk of underlying structural or metabolic cause; EEG essential |
| Infants (1-12 months) | Infantile spasms, focal seizures, febrile seizures (after 6 months) | West syndrome (infantile spasms), Dravet syndrome, benign infantile epilepsy | Infantile spasms are a neurological emergency; early treatment improves outcomes |
| Toddlers (1-3 years) | Febrile seizures (peak), generalized tonic-clonic, myoclonic, focal | Febrile seizures, Dravet syndrome, myoclonic-astatic epilepsy (Doose syndrome) | Febrile seizures most common; distinguish simple from complex; consider Dravet if recurrent with fever |
| Preschool (3-5 years) | Absence seizures begin, febrile seizures decline, focal seizures | Childhood absence epilepsy, Lennox-Gastaut syndrome, benign epilepsy with centrotemporal spikes | Absence seizures may be mistaken for inattention; request 3-second hyperventilation during exam |
| School-age (6-12 years) | Absence, focal with centrotemporal spikes, generalized tonic-clonic | Childhood absence epilepsy, benign epilepsy with centrotemporal spikes (Rolandic), Panayiotopoulos syndrome | Rolandic epilepsy has excellent prognosis; absence epilepsy may affect academic performance |
| Adolescents (12-18 years) | Generalized tonic-clonic, myoclonic, absence | Juvenile myoclonic epilepsy, juvenile absence epilepsy, focal epilepsies | Juvenile myoclonic epilepsy often triggered by sleep deprivation; lifelong treatment usually required |
Febrile Seizures: A Special Category
Simple Febrile Seizure
- Age 6 months to 5 years
- Generalized tonic-clonic
- Duration less than 15 minutes
- Does not recur within 24 hours
- No prior neurological abnormality
Recurrence risk: 30-35% overall; higher if first seizure before 12 months or low-grade fever
Epilepsy risk: 1-2% (slightly higher than general population)
Complex Febrile Seizure
- Focal features present
- Duration greater than 15 minutes
- Recurs within 24 hours
- Post-ictal focal deficit (Todd’s paralysis)
Recurrence risk: Higher than simple febrile seizures
Epilepsy risk: 4-15% depending on number of complex features
Key Concept: The First Seizure Framework
When evaluating a child with a first seizure, the clinician must answer four critical questions:
- Was this truly a seizure? Many paroxysmal events mimic seizures (syncope, breath-holding spells, movement disorders)
- What type of seizure? Focal versus generalized determines workup and management
- Was it provoked or unprovoked? Determines prognosis and need for treatment
- Is there an underlying epilepsy syndrome? Many pediatric epilepsy syndromes have characteristic features, EEG patterns, and prognoses
Impact on Quality of Life
Seizures in children have far-reaching effects beyond the ictal event itself. Children with epilepsy have higher rates of learning disabilities, attention deficit hyperactivity disorder, anxiety, and depression compared to their peers. Parental anxiety often leads to overprotection, which can limit the child’s independence and social development. Academic performance may suffer due to the seizures themselves, medication side effects, and comorbid cognitive difficulties. Sleep disturbance is common and may exacerbate seizure frequency. The unpredictable nature of seizures creates significant psychosocial burden for the entire family. Early recognition, appropriate treatment, and attention to comorbidities are essential to optimizing outcomes in children with seizures.
2. Pathophysiology and Mechanisms
Understanding the underlying mechanisms of seizures in children
Seizures result from an imbalance between excitatory and inhibitory neurotransmission in the brain, leading to hypersynchronous neuronal firing. The developing brain is particularly susceptible to seizures due to the relative predominance of excitatory neurotransmission, immature inhibitory systems, and ongoing synaptic plasticity. Understanding these mechanisms is essential for selecting appropriate antiseizure medications and predicting response to treatment.
The Excitation-Inhibition Balance
| Component | Normal Function | Role in Seizure Generation |
|---|---|---|
| Glutamate (Excitatory) | Primary excitatory neurotransmitter; essential for learning, memory, and synaptic plasticity | Excess glutamate release or receptor activation leads to neuronal hyperexcitability and seizure initiation |
| GABA (Inhibitory) | Primary inhibitory neurotransmitter; gamma-aminobutyric acid suppresses neuronal firing | Reduced GABAergic inhibition fails to contain excitatory activity; many antiseizure medications enhance GABA |
| Voltage-Gated Sodium Channels | Generate action potentials; essential for neuronal signaling | Increased channel activity or mutations cause repetitive firing; sodium channel blockers are effective antiseizure medications |
| Voltage-Gated Calcium Channels | Regulate neurotransmitter release and neuronal excitability | T-type calcium channels involved in absence seizures; ethosuximide blocks these channels |
| Potassium Channels | Repolarize neurons and limit repetitive firing | Reduced potassium channel function leads to prolonged depolarization and increased seizure susceptibility |
Developmental Susceptibility to Seizures
Why Are Children More Prone to Seizures?
The immature brain has several features that increase seizure susceptibility:
- GABA is excitatory in early development: Due to high intracellular chloride concentrations in immature neurons, GABA receptor activation causes depolarization rather than hyperpolarization in neonates
- Excess excitatory synapses: Synaptic density peaks in early childhood before pruning occurs
- Immature potassium channels: Reduced ability to repolarize and limit neuronal firing
- Incomplete myelination: Altered action potential propagation
- Higher metabolic rate: Greater vulnerability to metabolic disturbances
Mechanisms of Seizure Initiation and Propagation
| Phase | Cellular Events | Clinical Correlation |
|---|---|---|
| Initiation | Paroxysmal depolarizing shift in a group of neurons; burst of action potentials followed by hyperpolarization | Focal seizure onset; may be clinically silent if confined to small cortical area |
| Synchronization | Recruitment of surrounding neurons through synaptic connections and gap junctions | Seizure becomes clinically apparent; spread within a brain region |
| Propagation | Spread through white matter tracts, corpus callosum, or subcortical pathways | Focal to bilateral tonic-clonic progression; generalized seizure activity |
| Termination | Activation of inhibitory mechanisms, neuronal exhaustion, adenosine release, acidosis | Seizure stops spontaneously; post-ictal state reflects neuronal recovery |
Mechanisms by Seizure Type
Generalized Tonic-Clonic
Mechanism: Bilateral cortical hyperexcitability with thalamocortical involvement
Tonic phase: Sustained cortical and subcortical activation causing muscle rigidity
Clonic phase: Alternating excitation and inhibition producing rhythmic jerking
Treatment target: Sodium channels, GABA enhancement
Absence Seizures
Mechanism: Abnormal thalamocortical oscillations involving T-type calcium channels
Circuit: Reciprocal connections between thalamus and cortex generate 3 Hz spike-wave
GABA-B involvement: Enhanced GABA-B receptor activity paradoxically promotes absence seizures
Treatment target: T-type calcium channels (ethosuximide)
Focal Seizures
Mechanism: Localized cortical hyperexcitability, often due to structural lesion or focal cortical dysplasia
Semiology: Clinical manifestations reflect function of involved cortex (motor, sensory, autonomic)
Propagation: May spread locally or generalize via corpus callosum
Treatment target: Sodium channels, surgical resection if drug-resistant
How Specific Conditions Cause Seizures
| Condition | Mechanism | Treatment Implication |
|---|---|---|
| Febrile Seizures | Fever increases brain temperature, enhancing neuronal excitability; immature thermoregulation; possible viral or cytokine-mediated effects; genetic susceptibility in ion channels | Antipyretics do not prevent febrile seizures; intermittent benzodiazepines may reduce recurrence in high-risk children |
| Hypoglycemia | Neurons depend on glucose as primary energy source; ATP depletion impairs sodium-potassium ATPase, leading to depolarization and seizures | Immediate glucose administration; identify and treat underlying cause; prolonged hypoglycemia causes permanent injury |
| Hyponatremia | Cellular swelling due to osmotic water movement into neurons; altered neuronal excitability | Careful sodium correction to avoid osmotic demyelination; seizure risk highest when sodium falls rapidly below 120 mEq/L |
| Hypocalcemia | Calcium stabilizes neuronal membranes; low calcium increases neuronal excitability and neuromuscular irritability | Intravenous calcium gluconate for acute symptomatic hypocalcemia; address underlying cause |
| Meningitis/Encephalitis | Direct neuronal injury, inflammatory cytokines, cerebral edema, metabolic derangement, vascular compromise | Treat underlying infection; seizures may indicate complicated course; prophylactic antiseizure medication controversial |
| Hypoxic-Ischemic Encephalopathy | ATP depletion leads to failure of sodium-potassium ATPase; excitotoxic glutamate release; calcium influx triggers neuronal death | Therapeutic hypothermia neuroprotective; phenobarbital commonly used; seizures indicate moderate-severe injury |
| Focal Cortical Dysplasia | Abnormal cortical architecture with dysplastic neurons that have altered ion channel expression; intrinsically epileptogenic | Often drug-resistant; surgical resection may be curative if lesion can be completely excised |
| Dravet Syndrome | SCN1A gene mutation affects sodium channels in inhibitory interneurons; loss of inhibition leads to hyperexcitability | Avoid sodium channel blockers (may worsen seizures); valproate, clobazam, stiripentol, fenfluramine, cannabidiol are effective |
| Infantile Spasms (West Syndrome) | Abnormal cortical-subcortical interactions; hypothalamic-pituitary-adrenal axis involvement; multiple underlying etiologies | Adrenocorticotropic hormone or vigabatrin are first-line; early treatment improves developmental outcomes |
| Pyridoxine-Dependent Epilepsy | ALDH7A1 gene mutation causes accumulation of toxic metabolites that inhibit glutamate decarboxylase, reducing GABA synthesis | Lifelong pyridoxine (vitamin B6) supplementation; consider pyridoxine trial in neonatal seizures refractory to standard treatment |
Often Overlooked Mechanism: GABA-B in Absence Epilepsy
While most antiseizure medications work by enhancing GABAergic inhibition, this approach can paradoxically worsen absence seizures. GABA-B receptor activation in thalamocortical circuits promotes the oscillatory activity underlying absence seizures. This explains why medications like vigabatrin and tiagabine (which increase GABA levels) can exacerbate absence seizures, and why ethosuximide (which blocks T-type calcium channels without affecting GABA) is the first-line treatment for pure absence epilepsy.
Consequences of Prolonged Seizure Activity
| Time | Pathophysiological Changes | Clinical Implications |
|---|---|---|
| 0-5 minutes | Increased cerebral blood flow and metabolism compensate for increased demand | Seizure may self-terminate; monitor and prepare for intervention |
| 5-30 minutes | Failure of compensatory mechanisms; GABA receptor internalization; emergence of pharmacoresistance | Urgent treatment required; benzodiazepines become less effective with time |
| Greater than 30 minutes | Excitotoxic neuronal injury; systemic complications (hyperthermia, rhabdomyolysis, acidosis); cerebral edema | Risk of permanent neurological injury; aggressive treatment with multiple agents; intensive care required |
Genetic Mechanisms in Pediatric Epilepsy
Advances in genetic testing have revealed that many pediatric epilepsies have an underlying genetic cause. Understanding these mechanisms guides treatment selection and provides prognostic information.
| Gene | Channel/Protein Affected | Associated Syndrome | Treatment Implication |
|---|---|---|---|
| SCN1A | Sodium channel Nav1.1 | Dravet syndrome, genetic epilepsy with febrile seizures plus | Avoid sodium channel blockers; use valproate, clobazam, stiripentol |
| SCN2A | Sodium channel Nav1.2 | Early infantile epileptic encephalopathy, benign familial neonatal-infantile seizures | Gain-of-function: sodium channel blockers may help; Loss-of-function: avoid sodium channel blockers |
| KCNQ2 | Potassium channel Kv7.2 | Benign familial neonatal epilepsy, KCNQ2 encephalopathy | Sodium channel blockers often effective; retigabine (potassium channel opener) may help |
| SLC2A1 | Glucose transporter GLUT1 | GLUT1 deficiency syndrome | Ketogenic diet is treatment of choice; provides alternative brain fuel |
| TSC1/TSC2 | Hamartin/Tuberin (mTOR pathway) | Tuberous sclerosis complex | mTOR inhibitors (everolimus) can reduce seizures; vigabatrin first-line for infantile spasms |
Clinical Pearl: Precision Medicine in Pediatric Epilepsy
The era of precision medicine in epilepsy means that genetic diagnosis can directly inform treatment. For example:
- A child with SCN1A-related Dravet syndrome should never receive carbamazepine or lamotrigine (sodium channel blockers), as these can trigger status epilepticus
- A child with GLUT1 deficiency will not respond to conventional antiseizure medications but will dramatically improve with the ketogenic diet
- A child with pyridoxine-dependent epilepsy requires lifelong vitamin B6 supplementation
Consider genetic testing in any child with early-onset epilepsy, developmental delay with seizures, or drug-resistant epilepsy.
3. History Taking
A comprehensive approach to eliciting the seizure history in children
Red Flags — Require Urgent Evaluation
- Prolonged seizure (greater than 5 minutes) — Status epilepticus; immediate treatment required
- Seizure with fever and altered mental status — Meningitis or encephalitis until proven otherwise
- Focal neurological deficit post-seizure — Structural lesion, stroke, or Todd’s paralysis
- Seizure following head trauma — Intracranial hemorrhage or contusion
- First seizure in neonate — High likelihood of serious underlying cause
- Seizure with signs of increased intracranial pressure — Papilledema, bulging fontanelle, Cushing triad
- Multiple seizures without return to baseline — Status epilepticus by definition
- Seizure with hypoglycemia — Immediate glucose required; neuronal injury ongoing
- New seizure in immunocompromised child — Opportunistic central nervous system infection
- Seizure with petechial rash — Meningococcemia; requires immediate antibiotics
- Infantile spasms pattern — Neurological emergency; early treatment critical for outcome
- Seizure with suspected ingestion or poisoning — Toxicology workup; specific antidotes may exist
Systematic History: The “SEIZURE” Approach
Use the mnemonic “SEIZURE” to ensure comprehensive history taking in pediatric seizures:
- S — Start and Setting: What was the child doing when it started? Was there a warning (aura)? Where did the movements begin?
- E — Evolution and Events: How did the episode evolve? What movements occurred? Was consciousness preserved or impaired?
- I — Ictal details: Duration? Eye deviation? Cyanosis? Incontinence? Tongue biting? Automatisms?
- Z — Zero-in on triggers: Fever? Sleep deprivation? Flashing lights? Missed medications? Illness? Stress?
- U — Underlying conditions: Past medical history, birth history, development, prior seizures, family history of epilepsy
- R — Recovery (Post-ictal): How long to return to baseline? Sleepiness? Confusion? Weakness (Todd’s paralysis)? Headache?
- E — Effect on life: Impact on school, sleep, activities, family anxiety, any injuries during seizures?
Detailed Event Description
The most valuable information comes from witnesses who observed the event. If possible, ask witnesses to demonstrate what they saw, or review any video recordings captured on mobile phones. Video evidence can be invaluable for classification.
| Phase | Key Questions | Clinical Significance |
|---|---|---|
| Pre-ictal | “Was your child completely well before this happened? Any warning signs? Did they complain of anything unusual (funny feeling, smell, taste, fear)?” | Aura suggests focal onset; specific aura types localize seizure origin (epigastric rising = temporal lobe) |
| Ictal Onset | “What happened first? Where did the movements start? Did the eyes deviate? Which direction?” | Focal onset with secondary generalization suggests structural cause; eye deviation away from seizure focus |
| Ictal Evolution | “What did the movements look like? Stiffening? Jerking? Both? Did it spread from one area to another?” | Tonic-clonic pattern suggests generalized or focal to bilateral; Jacksonian march indicates focal motor cortex origin |
| Consciousness | “Could your child hear you? Respond to commands? Do they remember the episode?” | Preserved awareness suggests focal aware seizure; impaired awareness suggests focal impaired awareness or generalized |
| Associated Features | “Did they turn blue? Foam at the mouth? Bite their tongue? Lose bladder control? Make any sounds?” | Cyanosis indicates impaired respiration; tongue biting (lateral) specific for seizure; incontinence nonspecific but common in generalized seizures |
| Duration | “How long did the shaking last? Did anyone time it?” | Caregiver estimates often overestimate duration; greater than 5 minutes defines status epilepticus |
| Post-ictal | “How long until they were completely back to normal? Were they confused? Sleepy? Any weakness on one side?” | Prolonged post-ictal state suggests generalized seizure; Todd’s paralysis indicates focal motor seizure |
Targeted Questions by Suspected Cause
| Suspected Cause | Key Features | Ask This Question |
|---|---|---|
| Febrile Seizure | Age 6 months to 5 years, fever, generalized, brief | “Did your child have a fever? How high? How quickly did the temperature rise? Any source of infection?” |
| Meningitis/Encephalitis | Fever, headache, neck stiffness, altered mental status, photophobia | “Has your child been more irritable or lethargic? Complaining of headache or neck pain? Sensitive to light? Any rash?” |
| Hypoglycemia | Pallor, sweating, tremor, altered consciousness, diabetic child | “Does your child have diabetes? When did they last eat? Any sweating or shakiness before the event?” |
| Electrolyte Disturbance | Vomiting, diarrhea, poor intake, chronic illness | “Has your child had vomiting or diarrhea? How much fluid intake? Any chronic medical conditions?” |
| Toxic Ingestion | Access to medications, sudden onset, altered mental status | “Could your child have gotten into any medications or household products? What medications are in the home?” |
| Infantile Spasms | Clusters of brief flexor/extensor spasms, developmental regression, age 3-12 months | “Are the episodes occurring in clusters? Does your child seem to be losing skills they had before?” |
| Absence Epilepsy | Brief staring spells, immediate return to baseline, multiple daily episodes | “Does your child have staring spells where they seem to ‘blank out’? How often? Can you interrupt them?” |
| Juvenile Myoclonic Epilepsy | Morning myoclonic jerks, generalized tonic-clonic, adolescent onset | “Does your teenager have jerking movements in the morning? Do they drop things at breakfast? Any sleep deprivation?” |
| Temporal Lobe Epilepsy | Aura (déjà vu, fear, epigastric sensation), automatisms, impaired awareness | “Does your child describe any unusual feelings before the seizure? Fear? Strange taste or smell? Lip smacking or hand movements during?” |
| Frontal Lobe Epilepsy | Brief, nocturnal, hyperkinetic movements, minimal post-ictal state | “Do the seizures happen mainly at night? Are there unusual thrashing or bicycling movements? Does your child recover quickly?” |
Birth and Developmental History
Essential in All Pediatric Seizure Evaluations
The birth and developmental history provides critical clues to underlying etiology and helps identify children at higher risk for epilepsy.
Birth History
- Gestational age: Preterm infants at higher risk for seizures and epilepsy
- Birth weight: Small for gestational age may indicate intrauterine growth restriction
- Delivery complications: Prolonged labor, fetal distress, cord problems
- Apgar scores: Low scores suggest perinatal asphyxia
- NICU admission: Duration, reason, interventions required
- Neonatal seizures: Prior neonatal seizures increase epilepsy risk
- Intubation/ventilation: May indicate severe perinatal illness
- Neonatal infections: Meningitis, sepsis increase seizure risk
- Hyperbilirubinemia: Severe jaundice can cause kernicterus
Developmental History
- Motor milestones: Head control, sitting, walking — delays suggest underlying brain abnormality
- Language milestones: Babbling, first words, sentences
- Social milestones: Smiling, eye contact, interactive play
- Developmental regression: Loss of skills is a red flag for progressive condition or epileptic encephalopathy
- Current school performance: Learning difficulties may indicate underlying cognitive impairment
- Behavioral concerns: Autism spectrum, attention deficit hyperactivity disorder common comorbidities
Family History
| Family History Finding | Clinical Significance | Specific Syndromes to Consider |
|---|---|---|
| Febrile seizures in first-degree relatives | Increases risk of febrile seizures to 10-20% | Simple febrile seizures, genetic epilepsy with febrile seizures plus |
| Epilepsy in first-degree relatives | Suggests genetic susceptibility; 2-4 times increased risk | Childhood absence epilepsy, juvenile myoclonic epilepsy, benign epilepsy with centrotemporal spikes |
| Neonatal seizures in siblings | Consider benign familial neonatal epilepsy | KCNQ2-related epilepsy, benign familial neonatal-infantile epilepsy |
| Sudden unexplained death in family | Consider SUDEP risk, channelopathies affecting heart and brain | Dravet syndrome, long QT syndrome with seizures |
| Neurocutaneous findings in family | Autosomal dominant conditions may present variably | Tuberous sclerosis complex, neurofibromatosis |
| Consanguinity | Increases risk for autosomal recessive metabolic and genetic epilepsies | Pyridoxine-dependent epilepsy, neuronal ceroid lipofuscinosis, many others |
Medication and Social History
Medications That Can Cause Seizures
- Antihistamines (diphenhydramine overdose) — Anticholinergic toxicity
- Stimulants (methylphenidate, amphetamines) — Lower seizure threshold
- Tramadol — Lowers seizure threshold significantly
- Bupropion — Dose-dependent seizure risk
- Isoniazid — Pyridoxine depletion; treat with vitamin B6
- Theophylline — Narrow therapeutic window
- Cyclosporine/Tacrolimus — Posterior reversible encephalopathy syndrome
- Metoclopramide — Can cause dystonic reactions mimicking seizures
Antiseizure Medication History
- Current medications and doses
- Recent dose changes
- Compliance — missed doses?
- Recent illness affecting absorption
- Drug interactions
Social History
- Childcare/School: Exposure to illnesses; teachers may witness events
- Sleep habits: Sleep deprivation is a major trigger
- Screen time: Photosensitive epilepsy (video games, flashing lights)
- Recreational activities: Head injury risk assessment
- Adolescent concerns: Alcohol, recreational drugs, compliance with medication
- Household safety: Access to medications, chemicals
- Family stress: May affect compliance and seizure frequency
Immunization Status
- Up to date with vaccinations?
- Any seizures following immunization? (usually benign febrile seizures)
- Pertussis vaccination status (consider pertussis encephalopathy differential)
Seizure Mimics: Differentiating True Seizures
Key History Features That Suggest Non-Epileptic Events
4. Physical Examination
A systematic head-to-toe approach for pediatric seizures
Systematic Framework: Use the “Head to Extremities” approach for complete examination of children presenting with seizures. The examination has two key goals: (1) identify signs of acute illness requiring urgent intervention, and (2) detect findings suggesting an underlying etiology for the seizure.
General Inspection
- Level of consciousness: Alert, drowsy, lethargic, obtunded, comatose — document Glasgow Coma Scale or pediatric equivalent
- Respiratory pattern: Tachypnea, irregular breathing, apnea — may indicate ongoing seizure activity or central nervous system pathology
- Color: Cyanosis (ongoing seizure, respiratory compromise), pallor (anemia, shock), jaundice (metabolic disease)
- Posturing: Decorticate or decerebrate posturing indicates severe brain injury
- Activity: Spontaneous movements, response to stimulation, any ongoing seizure activity
- Dysmorphic features: May suggest genetic syndrome associated with epilepsy
- Nutritional status: Failure to thrive may indicate chronic illness or metabolic disorder
Vital Signs
Age-Appropriate Normal Values
Vital signs must be interpreted according to age-specific normal ranges. Post-ictal children commonly have tachycardia and mild hypertension that should normalize during the recovery period.
| Age | Heart Rate (beats per minute) | Respiratory Rate (breaths per minute) | Systolic Blood Pressure (mmHg) |
|---|---|---|---|
| Neonate (0-28 days) | 100-160 | 30-60 | 60-90 |
| Infant (1-12 months) | 100-150 | 25-40 | 80-100 |
| Toddler (1-3 years) | 90-140 | 20-30 | 90-105 |
| Preschool (3-5 years) | 80-120 | 20-25 | 95-110 |
| School-age (6-12 years) | 70-110 | 18-25 | 100-120 |
| Adolescent (12-18 years) | 60-100 | 12-20 | 110-130 |
| Vital Sign | Abnormal Finding | Clinical Significance |
|---|---|---|
| Temperature | Fever (greater than 38°C) | Febrile seizure; central nervous system infection; systemic infection as trigger |
| Temperature | Hypothermia | Sepsis in young infants; toxic ingestion; prolonged environmental exposure |
| Heart Rate | Tachycardia | Post-ictal state; fever; hypovolemia; medication effect; ongoing seizure activity |
| Heart Rate | Bradycardia | Increased intracranial pressure (Cushing reflex); toxic ingestion; cardiac arrhythmia |
| Blood Pressure | Hypertension | Post-ictal; increased intracranial pressure; posterior reversible encephalopathy syndrome; pheochromocytoma |
| Blood Pressure | Hypotension | Sepsis; toxic ingestion; status epilepticus with systemic compromise |
| Respiratory Rate | Tachypnea | Metabolic acidosis (diabetic ketoacidosis); respiratory infection; post-ictal |
| Oxygen Saturation | Less than 94% | Ongoing seizure; post-ictal hypoventilation; aspiration; respiratory infection |
| Glucose | Less than 60 mg/dL (3.3 mmol/L) | Hypoglycemia as cause; immediate treatment required |
Growth Parameters
Plot weight, height/length, and head circumference on appropriate growth charts. Abnormal growth patterns may indicate underlying syndromic or metabolic conditions.
| Finding | Consider |
|---|---|
| Microcephaly | Congenital infection (TORCH), genetic syndrome, brain malformation, in utero insult |
| Macrocephaly | Hydrocephalus, megalencephaly, subdural collections, storage disorders |
| Failure to thrive | Chronic illness, metabolic disorder, malabsorption, neglect |
| Short stature | Genetic syndrome, chronic medication effects, endocrine disorders |
Head and Fontanelle Examination
Fontanelle (Infants)
- Bulging fontanelle: Increased intracranial pressure — meningitis, hydrocephalus, intracranial hemorrhage
- Sunken fontanelle: Dehydration
- Premature closure: Craniosynostosis — may restrict brain growth
- Large fontanelle: Hydrocephalus, hypothyroidism, rickets, chromosomal abnormalities
Scalp and Skull
- Trauma signs: Bruising, swelling, lacerations — consider non-accidental injury in young children
- Cephalohematoma: May indicate birth trauma or coagulopathy
- Cranial bruits: Arteriovenous malformation
- Abnormal head shape: Plagiocephaly, craniosynostosis
Neurological Examination
The neurological examination is the cornerstone of seizure evaluation. Document findings carefully, as focal abnormalities direct workup toward structural or localized pathology.
Mental Status and Level of Consciousness
| Assessment | How to Test (Age-Appropriate) | Abnormal Findings and Significance |
|---|---|---|
| Alertness | Observe spontaneous activity; response to voice, touch, pain | Post-ictal drowsiness expected; prolonged altered consciousness suggests status, central nervous system infection, or structural lesion |
| Orientation | Ask name, age, location, date (school-age children and older) | Confusion indicates post-ictal state or encephalopathy |
| Interaction | Eye contact, social smile (infants); following commands; appropriate conversation | Poor interaction may indicate ongoing subclinical seizures or encephalopathy |
| Language | Spontaneous speech, naming, repetition, comprehension | Aphasia suggests dominant hemisphere involvement |
Cranial Nerves
| Cranial Nerve | Test | Abnormal Finding | Clinical Significance |
|---|---|---|---|
| II (Optic) | Pupillary response, visual fields, fundoscopy | Papilledema, visual field defect | Increased intracranial pressure; occipital lesion |
| III, IV, VI (Oculomotor, Trochlear, Abducens) | Eye movements, pupil size and reactivity | Gaze palsy, pupil asymmetry, ptosis | Brainstem lesion; herniation; III nerve palsy with aneurysm |
| VII (Facial) | Facial symmetry at rest and with movement | Facial weakness | Upper motor neuron (forehead sparing) vs lower motor neuron pattern; Todd’s paralysis |
| IX, X (Glossopharyngeal, Vagus) | Gag reflex, swallowing, voice quality | Absent gag, dysphagia, dysarthria | Brainstem dysfunction; aspiration risk |
| XII (Hypoglossal) | Tongue protrusion and movement | Tongue deviation, fasciculations | Tongue bite injury; lower motor neuron lesion |
Motor Examination
| Component | What to Assess | Significance of Abnormalities |
|---|---|---|
| Tone | Passive movement of limbs; head lag in infants; truncal tone | Hypotonia — metabolic, genetic, neuromuscular; Hypertonia — cerebral palsy, post-ictal; Asymmetry — focal lesion |
| Power | Spontaneous movement; resistance to gravity; formal strength testing in older children | Focal weakness suggests structural lesion or Todd’s paralysis; global weakness in metabolic or neuromuscular disease |
| Reflexes | Deep tendon reflexes; plantar response; primitive reflexes in infants | Asymmetry suggests focal pathology; hyperreflexia in upper motor neuron lesion; absent reflexes in lower motor neuron or shock |
| Coordination | Finger-nose-finger; heel-shin; gait observation; Romberg test | Ataxia suggests cerebellar or posterior fossa pathology; medication toxicity (phenytoin) |
Todd’s Paralysis
Focal weakness following a seizure (Todd’s paralysis) typically resolves within 24-48 hours. It indicates a focal seizure origin from the contralateral motor cortex. However, new focal deficits that persist or worsen require urgent neuroimaging to exclude stroke, tumor, or other structural lesion.
Skin Examination — Neurocutaneous Findings
The skin examination is essential in all children with seizures, as neurocutaneous syndromes frequently present with epilepsy. Use a Wood’s lamp to detect hypopigmented lesions in fair-skinned children.
| Finding | Description | Associated Condition |
|---|---|---|
| Ash-leaf spots | Hypopigmented macules, often lance-ovate shaped; may need Wood’s lamp | Tuberous sclerosis complex |
| Shagreen patch | Raised, flesh-colored plaque with orange-peel texture; typically lower back | Tuberous sclerosis complex |
| Facial angiofibromas | Red papules on face, especially nasolabial folds; appear in childhood | Tuberous sclerosis complex |
| Café-au-lait spots | Light brown macules; 6 or more larger than 5mm (prepubertal) is significant | Neurofibromatosis type 1 |
| Axillary freckling | Freckling in axillary or inguinal regions | Neurofibromatosis type 1 |
| Port-wine stain (facial) | Flat, pink-to-purple vascular malformation in trigeminal nerve distribution | Sturge-Weber syndrome |
| Linear sebaceous nevus | Yellow-orange waxy plaque, often on face or scalp | Linear sebaceous nevus syndrome (Schimmelpenning syndrome) |
| Incontinentia pigmenti | Evolving skin lesions: vesicles → verrucous → hyperpigmented whorls | Incontinentia pigmenti (X-linked dominant) |
| Petechiae/Purpura | Non-blanching lesions | Meningococcemia; thrombocytopenia; non-accidental injury |
Signs of Meningeal Irritation
Classic Signs
- Neck stiffness: Resistance to passive neck flexion
- Kernig sign: Pain with knee extension when hip is flexed
- Brudzinski sign: Involuntary hip flexion when neck is flexed
- Photophobia: Aversion to bright light
Important Caveats
- Infants: Classic signs often absent; look for irritability, bulging fontanelle, poor feeding
- Post-ictal: Neck stiffness may occur transiently post-ictally
- Sensitivity: Absence of meningeal signs does not exclude meningitis, especially in young children
Cardiovascular Examination
| Finding | Assessment | Significance for Seizure Evaluation |
|---|---|---|
| Heart murmur | Auscultate all areas; assess radiation | Congenital heart disease — risk of embolic stroke; bacterial endocarditis with embolic phenomena |
| Arrhythmia | Irregular rhythm; bradycardia; tachycardia | Long QT syndrome can present with seizure-like episodes (actually cardiac syncope) |
| Peripheral pulses | Femoral pulses; capillary refill | Coarctation of aorta (weak femorals) — associated with intracranial aneurysms |
Fundoscopic Examination
Critical Findings on Fundoscopy
- Papilledema: Indicates increased intracranial pressure — requires urgent neuroimaging before lumbar puncture
- Retinal hemorrhages: In an infant with seizures, consider abusive head trauma (shaken baby syndrome)
- Chorioretinitis: Suggests congenital infection (toxoplasmosis, cytomegalovirus)
- Retinal phakomas: Tuberous sclerosis complex
- Cherry-red spot: Storage disorders (Tay-Sachs disease, GM1 gangliosidosis)
Expected Findings by Etiology
| Etiology | General Appearance | Neurological Findings | Other Key Findings |
|---|---|---|---|
| Simple febrile seizure | Febrile, post-ictal drowsiness resolving | Normal neurological exam once recovered | Source of fever (otitis media, viral illness); normal development |
| Meningitis | Ill-appearing, febrile, irritable or lethargic | Meningeal signs; altered consciousness | Bulging fontanelle (infants); petechial rash (meningococcus) |
| Hypoglycemia | Pallor, diaphoresis, tremulous | Altered consciousness; may be normal post-treatment | Hepatomegaly (glycogen storage disease); insulin injection sites |
| Toxic ingestion | Variable; may have altered vital signs | Altered consciousness; miosis or mydriasis | Toxidrome signs (anticholinergic, cholinergic, sympathomimetic) |
| Tuberous sclerosis complex | Variable; may appear well | May be normal or have developmental delay | Ash-leaf spots, shagreen patch, facial angiofibromas |
| Intracranial hemorrhage | Variable; may have signs of trauma | Focal deficits; altered consciousness; signs of increased intracranial pressure | Scalp swelling; retinal hemorrhages in abusive head trauma |
| Idiopathic generalized epilepsy | Well-appearing between seizures | Normal examination | Normal development; positive family history |
| Infantile spasms (West syndrome) | May appear subdued; developmental plateau or regression | Hypotonia; developmental delay | May have findings of underlying cause (tuberous sclerosis, Down syndrome) |
Important Teaching Point
Normal examination is common! Many children with seizures, including those with epilepsy, have entirely normal physical examinations. A normal examination does not exclude significant underlying pathology. The history remains the most valuable component of seizure evaluation. However, any abnormality on examination should prompt thorough investigation, as it may provide crucial localizing or diagnostic information.
Developmental Assessment
A brief developmental assessment should be performed in all children with seizures. Developmental delay or regression is an important finding that influences the differential diagnosis and workup.
| Domain | Age-Appropriate Milestones to Assess | Significance of Delay |
|---|---|---|
| Gross Motor | Head control (3-4 months), sitting (6 months), walking (12-15 months) | Delay suggests underlying brain abnormality; consider cerebral palsy, genetic syndrome |
| Fine Motor | Reaching (4 months), pincer grasp (9 months), drawing (2-3 years) | Asymmetric use suggests hemiparesis |
| Language | Babbling (6 months), first words (12 months), two-word phrases (24 months) | Language delay common in epileptic encephalopathies; consider Landau-Kleffner syndrome if regression |
| Social | Social smile (2 months), stranger anxiety (9 months), pretend play (18-24 months) | Autism spectrum disorder commonly comorbid with epilepsy |
5. Differential Diagnosis
Systematic approach organized by probability, age, and clinical features
The differential diagnosis of seizures in children must consider both true seizures (epileptic events) and seizure mimics (non-epileptic paroxysmal events). Among true seizures, the clinician must determine whether the seizure is provoked (acute symptomatic) or unprovoked, as this distinction has major implications for prognosis and management.
First Seizure: Provoked vs Unprovoked
Step-by-Step Approach to a First Seizure:
- Step 1: Confirm this was truly a seizure — rule out seizure mimics
- Step 2: Is there an acute provoking factor? — fever, infection, metabolic disturbance, trauma, toxin
- Step 3: Classify the seizure type — focal vs generalized; motor vs non-motor
- Step 4: Is there an underlying epilepsy syndrome? — age of onset, seizure semiology, EEG pattern
- Step 5: Are there risk factors for recurrence? — abnormal EEG, abnormal neuroimaging, developmental delay, nocturnal seizure
Acute Symptomatic (Provoked) Seizures
| Probability | Etiology | Key Features | Red Flags |
|---|---|---|---|
| COMMON | Febrile seizure | Age 6 months to 5 years; fever greater than 38°C; generalized tonic-clonic; duration usually less than 5 minutes | Complex features (focal, prolonged, recurrent); age less than 6 months or greater than 5 years |
| COMMON | Viral illness with fever | Upper respiratory symptoms; gastroenteritis; roseola (human herpesvirus 6 notorious for febrile seizures) | Altered mental status out of proportion to fever; focal neurological signs |
| LESS COMMON | Hypoglycemia | Pallor, sweating, tremor, altered consciousness; diabetic child or prolonged fasting | Recurrent hypoglycemia; hepatomegaly; failure to thrive |
| LESS COMMON | Electrolyte disturbance | Hyponatremia (water intoxication, SIADH); hypocalcemia (rickets, hypoparathyroidism); hypomagnesemia | Severe derangement; failure to correct with standard treatment |
| LESS COMMON | Traumatic brain injury | History of head trauma; may have external signs of injury; immediate or early post-traumatic seizure | Prolonged loss of consciousness; focal deficit; signs of skull fracture |
| LESS COMMON | Toxic ingestion | Access to medications or toxins; altered mental status; toxidrome | Severe toxicity; unknown substance; cardiovascular instability |
| UNCOMMON BUT SERIOUS | Bacterial meningitis | Fever, irritability, bulging fontanelle (infants), neck stiffness (older children), petechial rash | Rapid deterioration; shock; purpuric rash; focal neurological signs |
| UNCOMMON BUT SERIOUS | Viral encephalitis | Fever, altered mental status, behavioral change, focal seizures; herpes simplex encephalitis most serious | Temporal lobe features; rapid progression; focal deficits |
| UNCOMMON BUT SERIOUS | Intracranial hemorrhage | Trauma history (or absent in non-accidental injury); headache; vomiting; altered consciousness | Signs of increased intracranial pressure; retinal hemorrhages in infant |
| UNCOMMON BUT SERIOUS | Hypertensive encephalopathy / Posterior reversible encephalopathy syndrome | Severely elevated blood pressure; headache; visual disturbance; altered mental status | End-organ damage; underlying renal disease |
Unprovoked Seizures and Epilepsy Syndromes by Age
Neonatal Period (0-28 days)
| Probability | Condition | Key Features | Prognosis |
|---|---|---|---|
| COMMON | Hypoxic-ischemic encephalopathy | Perinatal asphyxia; abnormal tone; depressed consciousness; seizures typically within first 24-72 hours | Variable; depends on severity; therapeutic hypothermia improves outcomes |
| COMMON | Intracranial hemorrhage | Preterm infants (intraventricular hemorrhage); term infants (subdural, subarachnoid); may have trauma history | Depends on extent; intraventricular hemorrhage grades III-IV have worse outcomes |
| LESS COMMON | Neonatal infections (meningitis, sepsis, TORCH) | Lethargy, poor feeding, temperature instability; group B streptococcus, Escherichia coli, Listeria common | Variable; early treatment critical |
| LESS COMMON | Benign familial neonatal epilepsy | Family history; onset day 2-7; brief clonic seizures; normal interictal examination | Excellent; seizures resolve by 6 months; normal development |
| LESS COMMON | Metabolic disorders | Poor feeding, lethargy, abnormal movements; pyridoxine-dependent epilepsy, non-ketotic hyperglycinemia, urea cycle defects | Variable; some treatable if diagnosed early (pyridoxine-dependent epilepsy) |
| UNCOMMON BUT SERIOUS | Brain malformations | Lissencephaly, holoprosencephaly, polymicrogyria; often have dysmorphic features; severe developmental delay | Generally poor; often drug-resistant epilepsy |
| UNCOMMON BUT SERIOUS | Early infantile epileptic encephalopathy (Ohtahara syndrome) | Onset first 3 months; tonic spasms; burst-suppression on EEG; often structural cause | Poor; high mortality; survivors have severe disability |
Infancy (1-12 months)
| Probability | Condition | Key Features | Prognosis |
|---|---|---|---|
| COMMON | Febrile seizures (after 6 months) | Associated with fever; generalized; brief; normal development | Excellent; 1-2% epilepsy risk for simple febrile seizures |
| LESS COMMON | Infantile spasms (West syndrome) | Clusters of flexor or extensor spasms; onset 3-12 months; hypsarrhythmia on EEG; developmental regression | Guarded; early treatment critical; many have underlying cause |
| LESS COMMON | Dravet syndrome | Prolonged febrile seizures in first year; later afebrile seizures; developmental plateau then regression; SCN1A mutation | Poor; drug-resistant epilepsy; cognitive impairment; SUDEP risk |
| LESS COMMON | Benign infantile epilepsy | Focal seizures in clusters; onset 3-8 months; normal development; may have family history | Excellent; seizures resolve; normal development |
| UNCOMMON | Tuberous sclerosis complex | Infantile spasms; hypopigmented macules; cardiac rhabdomyomas; cortical tubers on MRI | Variable; vigabatrin first-line for infantile spasms in tuberous sclerosis |
Early Childhood (1-5 years)
| Probability | Condition | Key Features | Prognosis |
|---|---|---|---|
| COMMON | Febrile seizures | Peak incidence 18 months; prevalence 2-5%; usually generalized tonic-clonic | Excellent; most outgrow by age 5-6 years |
| COMMON | Genetic epilepsy with febrile seizures plus | Febrile seizures persisting beyond age 6; afebrile seizures develop; family history; SCN1A, SCN1B mutations | Variable; ranges from benign to severe |
| LESS COMMON | Myoclonic-astatic epilepsy (Doose syndrome) | Onset 2-5 years; myoclonic and atonic seizures; falls; may have generalized tonic-clonic; normal prior development | Variable; 50-80% achieve seizure control; some cognitive difficulties |
| LESS COMMON | Lennox-Gastaut syndrome | Multiple seizure types (tonic, atonic, atypical absence); slow spike-wave on EEG; cognitive impairment | Poor; drug-resistant; progressive cognitive decline |
| LESS COMMON | Panayiotopoulos syndrome | Onset 3-6 years; autonomic symptoms (vomiting, pallor); prolonged seizures; often nocturnal; occipital spikes | Excellent; self-limited; resolves by adolescence |
School Age (6-12 years)
| Probability | Condition | Key Features | Prognosis |
|---|---|---|---|
| COMMON | Childhood absence epilepsy | Onset 4-10 years; brief staring spells (5-20 seconds); multiple daily; 3 Hz spike-wave; triggered by hyperventilation | Good; 70% remit by adolescence; 15% develop generalized tonic-clonic seizures |
| COMMON | Benign epilepsy with centrotemporal spikes (Rolandic epilepsy) | Onset 3-13 years; focal motor seizures involving face and arm; often nocturnal; centrotemporal spikes on EEG | Excellent; remits by age 16; normal development |
| LESS COMMON | Childhood occipital epilepsy (Gastaut type) | Onset 8-9 years; visual symptoms (elementary hallucinations, blindness); headache; occipital spikes | Variable; may persist into adulthood |
| LESS COMMON | Focal epilepsy (structural) | Focal seizures with semiology reflecting lesion location; focal cortical dysplasia, tumor, vascular malformation | Variable; surgery may be curative for focal lesions |
| UNCOMMON | Landau-Kleffner syndrome (epileptic aphasia) | Acquired aphasia; auditory agnosia; seizures in 70%; electrical status epilepticus in sleep | Variable; language may improve; cognitive outcomes variable |
Adolescence (12-18 years)
| Probability | Condition | Key Features | Prognosis |
|---|---|---|---|
| COMMON | Juvenile myoclonic epilepsy | Onset 12-18 years; morning myoclonic jerks; generalized tonic-clonic seizures; sleep deprivation trigger; photosensitivity | Good seizure control with medication; lifelong treatment usually required |
| COMMON | Juvenile absence epilepsy | Onset 10-17 years; less frequent absence than childhood form; generalized tonic-clonic common | Variable; less likely to remit than childhood absence epilepsy |
| LESS COMMON | Epilepsy with generalized tonic-clonic seizures alone | Generalized tonic-clonic without absence or myoclonus; often on awakening; EEG generalized spike-wave | Good; most respond to appropriate medication |
| LESS COMMON | Temporal lobe epilepsy | Aura (epigastric, fear, déjà vu); impaired awareness; automatisms; may have history of febrile seizures | Variable; mesial temporal sclerosis may require surgery |
| UNCOMMON | Progressive myoclonic epilepsies | Myoclonus, tonic-clonic seizures, progressive ataxia, cognitive decline; Lafora disease, Unverricht-Lundborg, neuronal ceroid lipofuscinosis | Poor; progressive neurodegenerative course |
Anatomical Approach to Focal Seizures
Frontal Lobe
Features: Brief, frequent, often nocturnal; hyperkinetic movements; minimal post-ictal state
Motor signs: Tonic posturing, clonic jerking, asymmetric tonic seizures
Causes: Focal cortical dysplasia, tumors, post-traumatic
Temporal Lobe
Features: Aura common (epigastric rising, fear, déjà vu); impaired awareness; automatisms (lip smacking, hand movements)
Post-ictal: Confusion, aphasia if dominant hemisphere
Causes: Mesial temporal sclerosis, tumors, focal cortical dysplasia
Parietal Lobe
Features: Sensory symptoms (tingling, numbness); may spread to motor cortex
Other: Spatial disorientation, body image distortion
Causes: Tumors, vascular malformations, focal cortical dysplasia
Occipital Lobe
Features: Visual symptoms (flashing lights, colors, blindness); may spread anteriorly
Post-ictal: Headache common
Causes: Occipital epilepsy syndromes, structural lesions
Non-Epileptic Paroxysmal Events (Seizure Mimics)
| Condition | Age Group | Key Features | Distinguishing Points |
|---|---|---|---|
| Breath-holding spells | 6 months to 6 years | Triggered by crying, pain, frustration; pallid or cyanotic; brief stiffening/jerking may occur | Clear precipitant; color change precedes any motor activity; rapid recovery |
| Reflex anoxic seizures | Infancy to early childhood | Vagal-mediated asystole; triggered by minor pain, startle; pallor, loss of consciousness, tonic posturing | Triggered by minor stimulus; pallor at onset; very brief; may have family history |
| Syncope | Any age, common in adolescents | Prodrome (lightheadedness, tunnel vision); occurs upright; brief jerking may occur (convulsive syncope) | Postural; prodrome present; rapid recovery; no post-ictal confusion |
| Night terrors | 2-6 years | First third of night; screaming, inconsolable, no memory; autonomic arousal | Occurs during non-REM sleep; child not responsive during event; no stereotyped movements |
| Parasomnias (sleepwalking, confusional arousals) | Childhood | Occur from deep sleep; complex behaviors; no memory of event | First third of night; non-stereotyped; responsive to redirection (sometimes) |
| Benign sleep myoclonus of infancy | Neonates and young infants | Rhythmic jerking only during sleep; stops when infant woken | Only during sleep; stops with arousal; normal EEG |
| Jitteriness in neonates | Neonates | Stimulus-sensitive tremor; stops with gentle restraint; no eye deviation or autonomic changes | Stimulus-sensitive; suppressible; symmetric tremor rather than clonic jerking |
| Tics | School age and adolescents | Stereotyped movements; preceded by urge; temporarily suppressible | Awareness preserved; can be suppressed; no post-event confusion |
| Stereotypies | Early childhood | Repetitive movements (hand flapping, body rocking); often with excitement; stoppable with distraction | Interruptible; awareness preserved; associated with autism spectrum or normal development |
| Psychogenic non-epileptic seizures | Older children and adolescents | Variable semiology; prolonged; eyes often closed; pelvic thrusting; waxing and waning | Variable pattern; preserved awareness despite apparent unresponsiveness; psychological comorbidity |
| Sandifer syndrome | Infants | Dystonic posturing associated with gastroesophageal reflux; head turning, arching | Related to feeds; no altered consciousness; responds to reflux treatment |
| Migraine with aura | School age and adolescents | Visual disturbance, sensory symptoms; followed by headache | Symptoms evolve slowly (minutes); headache follows; positive family history |
| Cardiac arrhythmias (long QT syndrome) | Any age | Syncope with exercise, emotion, or startle; may have convulsive features; family history of sudden death | Triggered by exercise, emotion, swimming; prolonged QTc on ECG; family history |
Drug-Induced Seizures
| Drug or Toxin | Mechanism | Clinical Features | Management Considerations |
|---|---|---|---|
| Diphenhydramine (antihistamine overdose) | Anticholinergic effects; sodium channel blockade at high doses | Tachycardia, mydriasis, dry skin, urinary retention, agitation, seizures | Benzodiazepines for seizures; physostigmine controversial; supportive care |
| Tricyclic antidepressants | Sodium channel blockade; anticholinergic; norepinephrine reuptake inhibition | Altered mental status, seizures, wide QRS, arrhythmias, hypotension | Sodium bicarbonate for cardiac toxicity; benzodiazepines for seizures |
| Isoniazid | Depletes pyridoxine (vitamin B6); inhibits GABA synthesis | Refractory seizures, metabolic acidosis, coma | Pyridoxine is specific antidote (gram-for-gram dosing) |
| Tramadol | Lowers seizure threshold; serotonergic effects | Seizures, serotonin syndrome features | Benzodiazepines; avoid in patients with seizure history |
| Bupropion | Lowers seizure threshold (dose-dependent) | Seizures, tachycardia, agitation | Benzodiazepines; supportive care |
| Sympathomimetics (amphetamines, cocaine) | Excessive catecholamine release; hyperthermia | Agitation, hyperthermia, hypertension, seizures, arrhythmias | Benzodiazepines; cooling; avoid beta-blockers |
| Organophosphates | Acetylcholinesterase inhibition; cholinergic excess | SLUDGE syndrome (salivation, lacrimation, urination, defecation, GI upset, emesis); seizures | Atropine, pralidoxime, benzodiazepines |
| Theophylline | Adenosine receptor antagonism; phosphodiesterase inhibition | Vomiting, tachycardia, arrhythmias, seizures (often refractory) | Benzodiazepines; consider hemodialysis for severe toxicity |
| Camphor | CNS stimulant; found in some topical preparations | Rapid onset seizures, altered mental status | Benzodiazepines; supportive care |
| Alcohol withdrawal | GABA downregulation; glutamate upregulation during chronic use | Seizures typically 6-48 hours after last drink; risk of delirium tremens | Benzodiazepines; supportive care; consider in adolescents |
Quick Reference: “If You See This, Think This”
| Clinical Clue | Think This First | Next Step |
|---|---|---|
| Infant with clusters of brief flexor spasms and developmental regression | Infantile spasms (West syndrome) | Urgent EEG; brain MRI; early treatment critical |
| Prolonged febrile seizures in first year with subsequent afebrile seizures | Dravet syndrome | Genetic testing (SCN1A); avoid sodium channel blockers |
| School-age child with frequent staring spells triggered by hyperventilation | Childhood absence epilepsy | EEG; ethosuximide or valproate first-line |
| Nocturnal focal motor seizures with centrotemporal spikes, normal development | Benign epilepsy with centrotemporal spikes | Reassurance; treatment often not needed; excellent prognosis |
| Adolescent with morning myoclonic jerks and generalized tonic-clonic seizures | Juvenile myoclonic epilepsy | EEG; valproate (caution in females) or levetiracetam; avoid sleep deprivation |
| Fever, altered mental status, focal seizures, CSF pleocytosis | Herpes simplex encephalitis | Immediate acyclovir; MRI; PCR for herpes simplex virus |
| Neonate with refractory seizures, no clear cause, burst suppression | Pyridoxine-dependent epilepsy or other metabolic disorder | Pyridoxine trial; metabolic workup; genetic testing |
| Infant with ash-leaf spots and infantile spasms | Tuberous sclerosis complex | Vigabatrin first-line; echocardiogram; renal ultrasound; genetic testing |
| Syncope during exercise or with emotion; family history of sudden death | Long QT syndrome | ECG with QTc measurement; cardiology referral; genetic testing |
| Toddler with breath-holding, cyanosis, then stiffening and brief jerking | Cyanotic breath-holding spell | Reassurance; iron studies; usually self-limited |
6. Diagnostic Investigations
A stepwise, evidence-based approach guided by clinical suspicion
The investigation of pediatric seizures should be guided by the clinical presentation, age of the child, and findings on history and examination. Not every child with a seizure requires extensive testing. The goals are to identify treatable causes, classify the seizure type and epilepsy syndrome, and guide management decisions.
Immediate Bedside Testing
Check Immediately in All Children with Active or Recent Seizure
- Blood glucose: Point-of-care testing; treat hypoglycemia immediately
- Oxygen saturation: Continuous monitoring during and after seizure
- Temperature: Identify febrile seizures; rule out CNS infection
- Heart rate and blood pressure: Identify hemodynamic instability
- Level of consciousness: Track post-ictal recovery; identify ongoing subtle seizures
- Pupil examination: Asymmetry suggests structural lesion or herniation
Laboratory Investigations
First Unprovoked Seizure — Routine Testing
| Investigation | When to Order | What to Look For | Practical Points |
|---|---|---|---|
| Blood glucose | All children with seizure | Hypoglycemia (less than 60 mg/dL or 3.3 mmol/L) | Point-of-care testing; if low, obtain formal lab glucose and investigate cause |
| Serum sodium | History of vomiting, diarrhea, excessive water intake; infants | Hyponatremia (less than 135 mEq/L); significant if less than 125 mEq/L | Water intoxication; SIADH; dilute formula; psychogenic polydipsia in older children |
| Serum calcium, magnesium | Neonates; infants; signs of tetany; history of malabsorption | Hypocalcemia (ionized calcium less than 4.0 mg/dL); hypomagnesemia | Correct ionized calcium for albumin; magnesium required for calcium correction |
| Complete blood count | If infection suspected; baseline if starting antiseizure medication | Leukocytosis (infection); anemia; thrombocytopenia | Not routinely needed for simple febrile seizures in well-appearing child |
| Basic metabolic panel | Prolonged seizure; status epilepticus; ill-appearing child | Electrolyte abnormalities; renal function; acidosis | Lactate elevated post-ictally (normalizes within hours) |
Evidence-Based Approach to Laboratory Testing
The American Academy of Pediatrics and American Academy of Neurology guidelines note that routine laboratory testing (electrolytes, glucose, calcium) has a low yield in well-appearing children with a first unprovoked seizure who have returned to baseline. Testing should be guided by clinical suspicion based on history and examination, not obtained reflexively.
Targeted Laboratory Investigations
| Clinical Scenario | Investigations to Consider | Rationale |
|---|---|---|
| Suspected CNS infection | Lumbar puncture (CSF cell count, protein, glucose, culture, HSV PCR); blood culture; procalcitonin | Meningitis and encephalitis are medical emergencies; HSV encephalitis requires early acyclovir |
| Suspected toxic ingestion | Toxicology screen; acetaminophen and salicylate levels; specific drug levels based on exposure | Identify treatable cause; guide antidote therapy |
| Neonatal seizures | Glucose, calcium, magnesium, electrolytes; ammonia; lactate; amino acids; urine organic acids; sepsis workup | High likelihood of metabolic or infectious cause; treatable conditions must not be missed |
| Suspected inborn error of metabolism | Ammonia, lactate, pyruvate, amino acids, acylcarnitine profile, urine organic acids, biotinidase | Early diagnosis allows specific treatment; sample during acute illness if possible |
| Refractory neonatal seizures | CSF glycine, serine, neurotransmitters; pyridoxine trial; genetic epilepsy panel | Non-ketotic hyperglycinemia, serine deficiency, pyridoxine-dependent epilepsy |
| Epilepsy on treatment | Antiseizure medication levels; complete blood count; liver function; renal function (drug-specific) | Monitor compliance, toxicity, and drug-specific complications |
Lumbar Puncture
Indications for Lumbar Puncture in Children with Seizures:
- Clinical signs of meningitis or encephalitis (fever with altered mental status, meningeal signs, petechial rash)
- Infants less than 6 months with febrile seizure (lower threshold due to unreliable clinical signs)
- Infants 6-12 months with febrile seizure if immunization status is incomplete or unknown (especially Haemophilus influenzae type b and Streptococcus pneumoniae)
- Child on antibiotics (may mask meningitis)
- Prolonged post-ictal altered mental status without clear explanation
- Suspected autoimmune encephalitis (anti-NMDA receptor encephalitis)
Contraindications: Signs of increased intracranial pressure; hemodynamic instability; coagulopathy; infection over puncture site. Obtain neuroimaging before lumbar puncture if increased intracranial pressure is suspected.
Electroencephalogram (EEG)
The EEG is the most important diagnostic test in epilepsy. It provides information about seizure type, epilepsy syndrome, and guides treatment decisions.
| EEG Type | Indications | Advantages | Limitations |
|---|---|---|---|
| Routine EEG (20-40 minutes) | First unprovoked seizure; suspected epilepsy; classification of epilepsy syndrome | Widely available; non-invasive; no sedation usually required | May miss interictal discharges; timing after seizure affects yield |
| Sleep-deprived EEG | Routine EEG non-diagnostic; suspected generalized epilepsy; juvenile myoclonic epilepsy | Increases yield for interictal discharges; captures sleep activation | May be difficult in young children; requires preparation |
| Prolonged video-EEG monitoring | Unclear diagnosis (seizure vs non-epileptic event); surgical evaluation; characterize seizure semiology | Captures clinical events with EEG correlation; gold standard for diagnosis | Resource-intensive; requires admission; may not capture events |
| Continuous EEG monitoring | Status epilepticus; critically ill child; coma; suspected non-convulsive seizures | Detects subclinical seizures; monitors treatment response | Requires ICU setting; expertise for interpretation |
| Ambulatory EEG | Frequent events not captured on routine EEG; home monitoring | Records in natural environment; captures sleep and wake cycles | No video correlation; electrode displacement; artifact |
EEG Findings by Epilepsy Syndrome
- Childhood absence epilepsy: 3 Hz generalized spike-wave, activated by hyperventilation
- Juvenile myoclonic epilepsy: 4-6 Hz generalized polyspike-wave
- Benign epilepsy with centrotemporal spikes: Centrotemporal spikes, activated by sleep
- Infantile spasms: Hypsarrhythmia (chaotic high-amplitude pattern)
- Lennox-Gastaut syndrome: Slow spike-wave (less than 2.5 Hz)
- Dravet syndrome: Initially normal; later generalized and multifocal discharges
Optimizing EEG Yield
- Timing: EEG within 24 hours of seizure has highest yield
- Sleep: Include sleep recording; many epilepsies show sleep activation
- Hyperventilation: Provokes absence seizures; perform for 3 minutes
- Photic stimulation: Identifies photosensitivity (juvenile myoclonic epilepsy)
- Age-appropriate interpretation: Normal patterns vary with age and state
- Serial EEGs: May be needed; single normal EEG does not exclude epilepsy
Clinical Pearl: EEG Interpretation
A normal EEG does not exclude epilepsy. Up to 50% of children with epilepsy may have a normal initial routine EEG. Conversely, epileptiform discharges can occur in children without epilepsy (approximately 3-5% of normal children). The EEG must always be interpreted in the clinical context. If the clinical history is highly suggestive of epilepsy, treatment may be initiated despite a normal EEG.
Neuroimaging
MRI Brain — The Preferred Imaging Modality
| Indication | Urgency | Specific Protocol Considerations |
|---|---|---|
| First unprovoked seizure with focal features | Urgent (within days to weeks) | Epilepsy protocol with thin cuts through temporal lobes |
| Focal neurological deficit | Urgent (within 24 hours) | Consider MRA if stroke suspected |
| Infantile spasms | Urgent (within days) | High-resolution imaging; may identify tuberous sclerosis, cortical dysplasia |
| Drug-resistant epilepsy | Semi-urgent | 3 Tesla MRI with epilepsy protocol; consider repeat imaging if prior was inadequate |
| Cognitive or developmental regression | Urgent | May identify progressive lesion or leukodystrophy |
| Abnormal neurological examination | Urgent | Tailored to clinical findings |
| First generalized seizure, normal development, normal examination | Non-urgent (elective) | May be deferred if EEG shows typical idiopathic generalized epilepsy pattern |
CT Brain — When to Use
| Indication for CT | Rationale | Limitations |
|---|---|---|
| Acute trauma with seizure | Rapid identification of intracranial hemorrhage, skull fracture | Poor resolution for subtle lesions; radiation exposure |
| Suspected intracranial hemorrhage | Rapidly available; sensitive for acute blood | MRI superior for subacute blood and underlying lesion |
| Signs of increased intracranial pressure (before lumbar puncture) | Rule out mass effect before LP | Does not definitively exclude elevated ICP |
| MRI not available or contraindicated | Better than no imaging in urgent situations | MRI should follow when available |
| Status epilepticus with unknown cause | Rapid assessment for treatable cause | MRI superior when patient stabilized |
Pediatric Imaging Considerations
- Radiation exposure: CT delivers significant radiation; use ALARA principles (As Low As Reasonably Achievable); prefer MRI when possible
- Sedation: Young children often require sedation for MRI; weigh risks and benefits; some centers offer “feed and wrap” for infants
- Contrast: Gadolinium contrast for MRI when tumor, infection, or inflammation suspected
- Epilepsy protocol MRI: Includes thin coronal cuts through hippocampi, FLAIR sequences, 3D volumetric imaging
Genetic Testing
Genetic testing has revolutionized the diagnosis and management of pediatric epilepsy. Identifying a genetic cause can guide treatment selection, provide prognostic information, and inform family counseling.
| Clinical Scenario | Recommended Testing | Key Genes/Findings |
|---|---|---|
| Infantile-onset epilepsy with developmental delay | Epilepsy gene panel or whole exome sequencing | SCN1A (Dravet), SCN2A, KCNQ2, CDKL5, STXBP1, many others |
| Infantile spasms | Chromosomal microarray; epilepsy gene panel; consider whole exome | TSC1/TSC2 (tuberous sclerosis), ARX, CDKL5, Down syndrome |
| Drug-resistant epilepsy | Epilepsy gene panel; pharmacogenomics | May identify precision therapy targets; HLA-B*15:02 (carbamazepine hypersensitivity in Asians) |
| Suspected Dravet syndrome | SCN1A sequencing and deletion/duplication analysis | SCN1A pathogenic variant in greater than 80% of Dravet syndrome |
| Suspected channelopathy (seizures plus cardiac arrhythmia) | Cardiac and epilepsy gene panel | SCN5A, KCNQ1, KCNH2 (cardiac); SCN1A, SCN2A (epilepsy) |
| Progressive neurological decline with epilepsy | Gene panel for neuronal ceroid lipofuscinoses, progressive myoclonic epilepsies; whole exome | CLN genes, EPM1, EPM2A/NHLRC1 (Lafora) |
| Suspected tuberous sclerosis complex | TSC1/TSC2 sequencing and deletion/duplication analysis | Clinical diagnosis possible; genetic confirmation aids family counseling |
Additional Specialized Investigations
Cardiac Evaluation
- ECG: All children with unexplained syncope; suspected long QT syndrome; before starting certain medications (sodium channel blockers)
- QTc measurement: Prolonged if greater than 460 ms (prepubertal) or greater than 470 ms (adolescent males) / greater than 480 ms (adolescent females)
- Echocardiogram: Suspected tuberous sclerosis (cardiac rhabdomyomas); structural heart disease
- Holter monitor: Intermittent arrhythmia suspected
Metabolic Studies
- CSF studies: Glucose (GLUT1 deficiency — CSF:serum glucose ratio less than 0.4), glycine, neurotransmitters, lactate
- Urine organic acids: Organic acidurias
- Plasma amino acids: Aminoacidopathies
- Acylcarnitine profile: Fatty acid oxidation defects
- Biotinidase activity: Biotinidase deficiency (treatable)
- Very long chain fatty acids: Peroxisomal disorders
Investigation Algorithms by Presentation
Simple Febrile Seizure in Well-Appearing Child
Minimal Workup Required:
- No routine laboratory tests, EEG, or neuroimaging required
- Identify and treat source of fever
- Lumbar puncture only if clinical signs of meningitis or child is incompletely immunized
- Educate family about febrile seizure recurrence and prognosis
First Unprovoked Seizure — Standard Workup
Recommended Investigations:
- EEG: Obtain within 24 hours if possible; sleep-deprived if routine non-diagnostic
- MRI brain: Recommended for all; urgent if focal seizure, focal deficit, or abnormal development
- Laboratory tests: Guided by clinical suspicion; not routine in well-appearing child
- Consider genetic testing: If syndromic features, developmental delay, or family history
Status Epilepticus — Emergency Workup
Concurrent with Treatment:
- Point-of-care glucose: Treat hypoglycemia immediately
- Basic metabolic panel: Electrolytes, renal function, glucose
- Complete blood count: Infection, anemia
- Blood gas: Acidosis, lactate
- Antiseizure medication levels: If on treatment
- Toxicology screen: If ingestion suspected
- CT head: If trauma or signs of increased ICP
- Lumbar puncture: If infection suspected (after imaging if ICP concern)
- Continuous EEG: When available; monitor for non-convulsive status
Neonatal Seizures — Comprehensive Workup
High Yield of Treatable Causes — Investigate Thoroughly:
- Glucose, calcium, magnesium, electrolytes
- Sepsis workup: Blood culture, urine culture, lumbar puncture (CSF studies, HSV PCR)
- Ammonia, lactate, blood gas
- Continuous EEG monitoring: Neonatal seizures often subtle; EEG essential
- MRI brain: Urgent; evaluate for hypoxic-ischemic injury, hemorrhage, malformation
- Metabolic workup: Amino acids, organic acids, acylcarnitine, biotinidase
- Pyridoxine trial: If seizures refractory to standard treatment
- Genetic testing: Epilepsy gene panel if cause not identified
7. Clinical Decision-Making
Practical algorithms and decision pathways for pediatric seizures
Step 1: Is This Urgent?
| Clinical Scenario | Urgency Level | Immediate Action |
|---|---|---|
| Active seizure greater than 5 minutes | EMERGENT | Initiate status epilepticus protocol; benzodiazepine immediately; airway management; call for help |
| Seizure with respiratory compromise or cyanosis | EMERGENT | Position airway; suction if needed; supplemental oxygen; prepare for ventilation support |
| Seizure with signs of increased intracranial pressure | EMERGENT | Elevate head of bed; avoid hypotension; urgent CT; neurosurgical consultation |
| Seizure with fever and altered mental status (meningitis suspected) | EMERGENT | Blood cultures; empiric antibiotics immediately; lumbar puncture when safe; acyclovir if encephalitis suspected |
| Seizure with hypoglycemia | EMERGENT | IV dextrose immediately (2-4 mL/kg of D25W in children; 2 mL/kg of D10W in neonates) |
| Infantile spasms (new diagnosis) | URGENT | Urgent EEG; brain MRI; initiate treatment within days (ACTH or vigabatrin); pediatric neurology referral |
| First focal seizure with post-ictal deficit | URGENT | Urgent neuroimaging (CT if MRI not immediately available); neurology consultation |
| First unprovoked seizure, now at baseline | URGENT | EEG within 24 hours if possible; outpatient MRI; neurology referral within 1-2 weeks |
| Simple febrile seizure, well-appearing child | ROUTINE | Identify fever source; parental education; no routine investigations; follow-up with pediatrician |
| Known epilepsy with typical breakthrough seizure | ROUTINE | Assess compliance; check medication levels if applicable; adjust treatment if pattern changing; routine follow-up |
Step 2: Was This Truly a Seizure?
Key Differentiating Features:
- Seizure: Stereotyped; not interruptible; may have post-ictal state; eye deviation; rhythmic movements evolving over time
- Syncope: Postural; prodrome of lightheadedness; brief duration; rapid recovery; brief jerking possible (convulsive syncope)
- Breath-holding spell: Clear precipitant (crying, pain); color change precedes motor activity; rapid recovery
- Psychogenic event: Variable semiology; eyes often closed; waxing/waning; preserved awareness despite apparent unresponsiveness
When uncertain: Video-EEG monitoring is the gold standard for distinguishing seizures from mimics.
Step 3: Classify the Seizure
Provoked (Acute Symptomatic)
Identifiable acute cause within 7 days
- Febrile seizure
- Metabolic disturbance
- CNS infection
- Acute head trauma
- Toxic ingestion
Action: Treat underlying cause; antiseizure medication usually not needed long-term
Unprovoked — First Seizure
No identifiable acute provoking factor
- Recurrence risk 30-50%
- Higher if abnormal EEG
- Higher if abnormal MRI
- Higher if nocturnal seizure
Action: EEG and MRI; treatment decision individualized
Epilepsy
Two or more unprovoked seizures greater than 24 hours apart; OR one seizure with high recurrence risk
- Identify epilepsy syndrome
- Guide treatment selection
- Provide prognosis
Action: Initiate antiseizure medication; long-term management plan
Step 4: Should I Start Antiseizure Medication?
| Clinical Situation | Recommendation | Rationale |
|---|---|---|
| Simple febrile seizure | NO — Do not treat | Excellent prognosis; no evidence that treatment prevents epilepsy; medication side effects outweigh benefits |
| First unprovoked seizure, normal EEG and MRI | CONSIDER — Shared decision-making | 30-40% recurrence risk; treatment reduces recurrence but does not change long-term prognosis; discuss risks/benefits with family |
| First unprovoked seizure with abnormal EEG or MRI | CONSIDER — Lower threshold to treat | Higher recurrence risk (60-70%); treatment may be reasonable; individualize based on seizure impact and family preference |
| Two or more unprovoked seizures (epilepsy) | YES — Generally treat | High recurrence risk; treatment improves seizure control and quality of life |
| Benign epilepsy with centrotemporal spikes (infrequent seizures) | CONSIDER — Treatment optional | Excellent prognosis; seizures often nocturnal and infrequent; may observe without treatment |
| Infantile spasms | YES — Treat urgently | Developmental emergency; early treatment improves outcomes; ACTH or vigabatrin first-line |
| Childhood absence epilepsy | YES — Treat | Frequent seizures impact learning and safety; excellent response to medication |
Antiseizure Medication Selection by Seizure Type
| Seizure/Syndrome Type | First-Line Options | Alternatives | Avoid |
|---|---|---|---|
| Focal seizures | Levetiracetam, oxcarbazepine, carbamazepine | Lamotrigine, lacosamide, topiramate | Ethosuximide (not effective) |
| Generalized tonic-clonic | Valproate, levetiracetam, lamotrigine | Topiramate, zonisamide | Carbamazepine, oxcarbazepine (may worsen) |
| Absence seizures | Ethosuximide (pure absence), valproate | Lamotrigine | Carbamazepine, oxcarbazepine, phenytoin, vigabatrin (worsen absence) |
| Juvenile myoclonic epilepsy | Valproate (caution in females), levetiracetam | Lamotrigine (may worsen myoclonus in some), topiramate | Carbamazepine, phenytoin (worsen myoclonus) |
| Infantile spasms | ACTH (adrenocorticotropic hormone), vigabatrin (especially if tuberous sclerosis) | Oral corticosteroids, topiramate | Standard antiseizure medications generally ineffective |
| Dravet syndrome | Valproate, clobazam, stiripentol | Cannabidiol, fenfluramine, topiramate | Sodium channel blockers (carbamazepine, oxcarbazepine, lamotrigine, phenytoin) — may trigger status epilepticus |
| Lennox-Gastaut syndrome | Valproate, lamotrigine, rufinamide | Clobazam, topiramate, cannabidiol, felbamate | Often drug-resistant; multiple medications needed |
| Benign epilepsy with centrotemporal spikes | Levetiracetam, carbamazepine, oxcarbazepine | Valproate, sulthiame (Europe) | Often no treatment needed; excellent prognosis |
Critical: Medications to Avoid in Specific Syndromes
- Dravet syndrome: NEVER use sodium channel blockers (carbamazepine, oxcarbazepine, lamotrigine, phenytoin) — can trigger prolonged seizures and status epilepticus
- Absence epilepsy: Avoid carbamazepine, oxcarbazepine, phenytoin, gabapentin, vigabatrin, tiagabine — may worsen absence seizures
- Juvenile myoclonic epilepsy: Avoid carbamazepine, phenytoin, gabapentin — may worsen myoclonus
- Myoclonic-astatic epilepsy: Avoid carbamazepine — may worsen seizures
“What Do I Do If…” Decision Reference
| Clinical Situation | Immediate Action | Next Step |
|---|---|---|
| Child seizing in front of me | Time the seizure; protect from injury; position on side; do NOT restrain or put anything in mouth | If greater than 5 minutes, give benzodiazepine; call for help; prepare airway equipment |
| Seizure stopped but child not waking up | Ensure airway patent; monitor vital signs; check glucose | If prolonged, consider non-convulsive status; obtain EEG; evaluate for underlying cause |
| Parent describes episode but child now normal | Detailed history of event; complete examination including neurological | Determine if seizure vs mimic; arrange appropriate investigations; safety counseling |
| Febrile seizure — complex features (prolonged, focal, recurrent) | Ensure seizure stopped; evaluate for meningitis; check glucose | Consider lumbar puncture; EEG; MRI if focal; neurology referral; counsel about Dravet syndrome risk if very prolonged |
| Known epilepsy patient with increased seizure frequency | Assess compliance; check for triggers (illness, sleep deprivation); verify medication supply | Check drug levels; consider dose adjustment; evaluate for new diagnosis; neurology follow-up |
| Teenager with first seizure after night of poor sleep | Full evaluation for first seizure; ask about morning myoclonic jerks | High suspicion for juvenile myoclonic epilepsy; EEG with sleep deprivation; counsel about lifestyle triggers |
| Infant with clusters of brief jerking movements | Detailed description; video if possible; developmental assessment | High suspicion for infantile spasms; urgent EEG; MRI; immediate neurology referral — this is a developmental emergency |
| Child with epilepsy starting new medication and develops rash | Assess rash severity; check for mucosal involvement; assess for systemic symptoms | If mild, may observe; if severe, blistering, or mucosal involvement — stop medication immediately; consider Stevens-Johnson syndrome/DRESS |
| Parent asks about driving/sports/swimming | Discuss seizure control; assess individual risk; review local regulations | Driving: typically seizure-free period required (varies by jurisdiction); swimming: supervised, no diving; sports: individualize based on seizure control |
Status Epilepticus Management Algorithm
Definition: Seizure lasting greater than 5 minutes OR two or more seizures without return to baseline
Status epilepticus is a medical emergency. Time is brain — treatment should begin immediately.
| Time | Stage | Action | Medication (Weight-Based Dosing) |
|---|---|---|---|
| 0-5 minutes | Stabilization | ABCs; position; oxygen; glucose check; IV access; time seizure | — |
| 5-10 minutes | First-line therapy | Benzodiazepine | IV lorazepam 0.1 mg/kg (max 4 mg) OR IV diazepam 0.2 mg/kg (max 10 mg) OR IM midazolam 0.2 mg/kg (max 10 mg) OR intranasal midazolam 0.2 mg/kg OR rectal diazepam 0.5 mg/kg |
| 10-15 minutes | Repeat first-line | If still seizing, repeat benzodiazepine once | Same dose as above; maximum 2 doses of benzodiazepine |
| 15-30 minutes | Second-line therapy | Antiseizure medication load | IV fosphenytoin 20 mg PE/kg (max 1500 mg PE) OR IV levetiracetam 60 mg/kg (max 4500 mg) OR IV valproate 40 mg/kg (max 3000 mg) |
| 30-60 minutes | Refractory status | Repeat second-line agent OR proceed to third-line | May give additional second-line agent; prepare for anesthetic agents; ICU transfer |
| Greater than 60 minutes | Super-refractory status | Continuous infusion anesthetic; ICU care; continuous EEG | Midazolam infusion 0.1-0.4 mg/kg/hour OR pentobarbital OR propofol (caution in children — propofol infusion syndrome risk) |
When to Refer to Pediatric Neurology
Urgent Referral (Within Days)
- Suspected infantile spasms
- New focal seizures
- Seizures with developmental regression
- Abnormal neuroimaging
- Complex febrile seizures (especially if prolonged or multiple)
- Neonatal seizures
- Status epilepticus
Routine Referral (Within Weeks)
- First unprovoked seizure
- Suspected absence epilepsy
- Suspected juvenile myoclonic epilepsy
- Epilepsy not well-controlled on initial medication
- Diagnostic uncertainty (seizure vs mimic)
- Family request for subspecialty evaluation
- Pre-surgical evaluation consideration
Troubleshooting Refractory Seizures
Ask These Questions When Seizures Are Not Controlled
- Is this truly epilepsy? Up to 20-30% of patients referred for drug-resistant epilepsy have psychogenic non-epileptic seizures; video-EEG is essential
- Is the diagnosis correct? Wrong syndrome diagnosis leads to wrong medication; reassess seizure type and syndrome
- Is the medication appropriate for this seizure type? Some medications worsen certain seizure types (e.g., carbamazepine in absence epilepsy)
- Is the dose adequate? Check drug levels; ensure therapeutic range
- Is compliance good? Missed doses are a common cause of breakthrough seizures; non-judgmental discussion with family
- Are there modifiable triggers? Sleep deprivation, alcohol (adolescents), medication interactions, illness
- Is there a progressive underlying condition? Tumor, neurodegenerative disease, autoimmune encephalitis
- Should surgery be considered? Focal epilepsy with identifiable lesion may be curable with surgery; refer to comprehensive epilepsy center
- Are there alternative therapies? Ketogenic diet, vagus nerve stimulation, responsive neurostimulation
8. Clinical Pearls and Pitfalls
Practical wisdom — learn from experience and avoid common mistakes
Must-Know Clinical Pearls
Critical Pitfalls to Avoid
Key Takeaways
- Seizures are common in children, affecting 4-10% during childhood; most have excellent outcomes with appropriate management.
- The distinction between provoked (acute symptomatic) and unprovoked seizures is fundamental — it determines prognosis and guides the decision to treat.
- Febrile seizures are the most common seizure type in children; simple febrile seizures require only reassurance and fever source identification — not antiseizure medications or extensive workup.
- Status epilepticus is a medical emergency; treatment should begin after 5 minutes of continuous seizure activity. Early treatment is more effective than delayed treatment.
- Infantile spasms are a developmental emergency requiring urgent diagnosis and treatment. Any suspicion should prompt immediate EEG and neurology referral.
- Identifying the specific epilepsy syndrome guides medication selection — some medications that help one syndrome can worsen another. Know which drugs to avoid in absence epilepsy, juvenile myoclonic epilepsy, and Dravet syndrome.
- A normal EEG does not exclude epilepsy, and a normal physical examination does not exclude serious pathology. The clinical history remains the cornerstone of diagnosis.
- Genetic testing should be considered early in infantile-onset epilepsy, epilepsy with developmental delay, and drug-resistant epilepsy — it may reveal the cause and guide precision treatment.
- Many childhood epilepsy syndromes have excellent prognoses with high remission rates (childhood absence epilepsy, benign epilepsy with centrotemporal spikes). Provide families with realistic, hopeful counseling.
- Children with epilepsy have high rates of comorbidities including learning disabilities, attention deficit hyperactivity disorder, anxiety, and depression. Address these to optimize quality of life.
Quick Reference Algorithm
Systematic Approach to Pediatric Seizures:
- Stabilize: ABCs, position safely, time the seizure, check glucose, establish IV access
- Stop the seizure: If greater than 5 minutes, initiate benzodiazepine; follow status epilepticus protocol if needed
- Confirm: Was this truly a seizure? Obtain detailed history and consider mimics
- Classify: Provoked vs unprovoked; focal vs generalized; identify epilepsy syndrome if applicable
- Investigate: Guided by clinical presentation — EEG for all unprovoked seizures; MRI if focal features, abnormal exam, or developmental concerns; laboratory tests based on clinical suspicion
- Treat: Address underlying cause for provoked seizures; individualize antiseizure medication decision for unprovoked seizures based on recurrence risk and family preference
- Counsel: Educate family about seizure first aid, safety precautions, medication adherence, when to seek emergency care, and prognosis
- Follow up: Ensure appropriate neurology referral; monitor treatment response; address comorbidities and quality of life